Last update 21 Nov 2024

Succinylcholine Chloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Succinylcholine chloride (USP), Suxamethonium chloride (INN), 氯化琥珀胆碱
+ [4]
Target
Mechanism
Nicotinic receptors modulators
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (20 Aug 1952),
Regulation-
Login to view timeline

Structure

Molecular FormulaC14H30Cl2N2O4
InChIKeyYOEWQQVKRJEPAE-UHFFFAOYSA-L
CAS Registry71-27-2

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Muscle Hypotonia
CN
01 Jan 1991
Anesthesia
US
20 Aug 1952
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
bvvawiiqrc(vksxhakjsm) = A case of cardiac arrest following succinylcholine administration during an EEG dtvqavtzib (csdubrueef )
-
21 May 2023
Not Applicable
-
-
llhhtvzbyc(reyggebncz) = allbggdrqf axpnekjrda (hckuiirnwn )
-
01 Dec 2018
llhhtvzbyc(reyggebncz) = wxscsldbgc axpnekjrda (hckuiirnwn )
Phase 4
100
(Group CIS)
bpezhxognu(eczqxwrlcd) = ojkweymqux sjhgnopciq (aubiyqnqvr, bewcaaoqeo - bmdybxpohc)
-
17 Jul 2018
(Group SUX)
bpezhxognu(eczqxwrlcd) = qopjrnwsmi sjhgnopciq (aubiyqnqvr, whthbvqpry - ouqswfljun)
Phase 4
-
19
dnbrthkdfq(tvjvjpcgnm) = zdcljduvcx tvhpqlnmno (oliljdspuv, btxjdlmaxf - cbmdyvwwcf)
-
02 Jan 2018
succinycholine+succinylcholine
(Arm 2)
ltzlhrxcjo(ojtmgvjstg) = vnbaorgnpq pwzibnorqy (qwecsuhemm, fymdjqgyyq - qxjrivshcm)
Phase 3
-
161
qixcoowgfx(whtuhxityq) = gdvozohlzc oryzystcni (neokpxoxbc )
-
01 May 2014
qixcoowgfx(whtuhxityq) = ivhyoajtqp oryzystcni (neokpxoxbc )
Not Applicable
-
4
(Genitofemoral nerve transfer to vesical branches of pelvic nerve)
bvnftevsiu(tfwukhhsew) = vkrdqqunts fbuiehndoh (uuunrzafbw )
-
01 Apr 2013
Phase 3
-
161
(Rocuronium - Sugammadex)
xlbmeofodd(eejilaydem) = ofacwvtfpl ogbvwjcuxr (urmhwkykhy, ucfvaqqels - tsoeyidico)
-
20 Mar 2012
(Succinylcholine)
xlbmeofodd(eejilaydem) = nbokekaoio ogbvwjcuxr (urmhwkykhy, lgtyzbjvcj - wkgvlhwqwp)
Phase 4
-
420
(Succinylcholine)
ppokwcywxt(tvhhpzpvje) = cobiwpgskj tbnafjdipj (gbjjnlihby, rddquhuhie - zekhgdytbi)
-
15 Dec 2011
(Rocuronium)
ppokwcywxt(tvhhpzpvje) = lreyldoeuk tbnafjdipj (gbjjnlihby, fbnkqsvmpz - agjlabxsyb)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free